Colombia vs Republic of Korea: Share of adolescent girls vaccinated against human papillomavirus
Colombia
63.0%
in 2024
Republic of Korea
65.0%
in 2024
Colombia rank
41st
Republic of Korea rank
38th
Share of adolescent girls vaccinated against human papillomavirus over time
- Colombia
- Republic of Korea
How they compare
Republic of Korea currently reports 65.0% against 63.0% in Colombia, a difference of 2.0%.
The two have swapped places 1 time across 7 shared years of data; in 2018 it was Colombia ahead.
Colombia ranks 41st and Republic of Korea ranks 38th of 74 countries.
Across the 2 decades both report, Colombia averaged higher in 1 and Republic of Korea in 1.
Head to head by decade
| Decade | Colombia | Republic of Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.0% | 55.5% | 15.5% | Colombia |
| 2020s | 36.2% | 69.4% | 33.2% | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of adolescent girls vaccinated against human papillomavirus, Colombia or Republic of Korea?
- Republic of Korea, at 65.0% against 63.0% in Colombia as of 2024.
- What is the difference in share of adolescent girls vaccinated against human papillomavirus between Colombia and Republic of Korea?
- 2.0%, with Republic of Korea ahead.
- How many years of comparable data are there for Colombia and Republic of Korea?
- 7 years are reported by both, from 2018 to 2024.
- How do Colombia and Republic of Korea rank globally for share of adolescent girls vaccinated against human papillomavirus?
- Colombia ranks 41st and Republic of Korea ranks 38th of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as Share of adolescent girls vaccinated against human papillomavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.